Gut Bacteria Predict Skin Cancer Recurrence, Study Finds
NYU Langone links gut bacteria to skin cancer recurrence, but only when patients share a microbial fingerprint — reframing earlier optimism about microbiome biomarkers.
Topic
Non Melanoma Skin Cancer
Topic
Non Melanoma Skin Cancer
FDA Approves Light-Based Therapy for a Common Skin Cancer
The FDA has approved a light-based treatment for a common skin cancer, adding a nonsurgical phototherapy option for non-melanoma…
UC San Diego Health First Hospital to Deploy CivaDerm Radioactive Bandage for Skin Cancer
UC San Diego Health has become the first hospital to use CivaDerm, a radioactive bandage for treating skin cancer — a first-in-ho…
CivaTech's CivaDerm Reaches First Commercial Use in Skin Cancer
CivaTech Oncology of Morrisville announces first commercial use of CivaDerm for non-melanoma skin cancer, moving the device into…
FDA Approval of Ameluz Expands Skin Cancer Treatment Options
The FDA has approved Ameluz, a decision specialists hail as a meaningful addition to the skin cancer treatment armamentarium, Med…
Rhenium-188 Epidermal Radionuclide Therapy in Non-Melanoma Skin Cancer
A Frontiers narrative review surveys epidermal radionuclide therapy with rhenium-188, a topical beta-emitter approach to basal an…
Preclinical Data Suggest New Cream May Slow Common Skin Cancers
Penn Medicine reports preclinical evidence that a new topical cream may prevent or slow growth of common skin cancers; no human d…